查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047013

止鼾設備和止鼾手術市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、地區和競爭格局分類，2021-2031年

Anti-snoring Devices and Snoring Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球止鼾設備和止鼾手術市場預計將從 2025 年的 17.2 億美元大幅成長至 2031 年的 26.9 億美元，複合年成長率為 7.74%。

該領域涵蓋多種解決方案，從旨在確保氣道通暢的非侵入性設備（例如口腔矯正器、鼻擴張器和持續性正壓呼吸器 (CPAP) 設備）到旨在矯正導致打鼾的結構性阻塞的外科手術。推動這一領域發展的主要因素是全球肥胖症盛行率的上升和老年人口的成長，這兩者都更容易出現睡眠呼吸障礙。

市場概覽
預測期 2027-2031
市場規模：2025年 17.2億美元
市場規模：2031年 26.9億美元
複合年成長率：2026-2031年 7.74%
成長最快的細分市場 下巴帶
最大的市場 北美洲

例如，美國國家老齡委員會的報告指出，到2025年，約56%的65歲及以上成年人將面臨阻塞型睡眠呼吸中止症的高風險。這凸顯了老齡化與睡眠障礙之間的密切聯繫，並表明人們對有效治療方法（包括手術和非手術方法）的需求持續存在。然而，限制市場成長的主要因素是患者對這些設備的依從性和舒適度。相當一部分使用者在使用CPAP面罩和下顎前突矯正器時會感到不適和恐懼症，導致較高的治療中斷率。這種對長期治療方案的抗拒不僅限制了製造商的潛在收入，也對止鼾技術的全球推廣構成了重大障礙。

市場促進因素

市場擴張的主要驅動力是阻塞型睡眠呼吸中止症（OSA）在全球範圍內的盛行率激增，而這主要是由於肥胖率上升和全球人口老化所致。隨著生活方式相關的呼吸系統疾病日益普遍，需要臨床干預的人數顯著增加，從而推動了對先進診斷工具和治療方法的需求。瑞思邁（ResMed）在2025年8月發布的新聞稿也反映了這一日益成長的健康負擔，該新聞稿預測，到2050年，美國將有約7700萬成年人患有OSA。 OSA盛行率的激增直接轉​​化為行業主要參與者的商業活動活性化和財務成長。

受此經濟影響，瑞思邁（ResMed）預計2025年季度銷售額將達到13億美元，主要得益於睡眠健康設備和麵罩的穩定需求。同時，微創手術的需求顯著成長，重塑了治療方法，尤其對於那些難以堅持傳統非侵入性療法的患者而言更是如此。諸如舌下神經刺激術等外科治療方法正日益普及，它為解剖結構阻塞提供了一種持久的解決方案，且避免了持續性正壓呼吸器（CPAP）設備通常帶來的不適感。技術進步透過改善患者預後和降低手術複雜性，進一步加速了這些手術的普及。例如，Inspire Medical Systems公司在2025年11月報告稱，超過75%的臨床中心已準備好部署其新型系統Inspire V。這表明，在嚴重睡眠障礙的治療方面取得了顯著進展，先進的微創治療正成為首選方案。

市場挑戰

在打鼾治療和睡眠手術市場，患者的治療順從性是影響產生收入的主要障礙。儘管睡眠障礙的普遍存在預示著治療設備的蓬勃發展，但傳統治療方法的侵入性，尤其是持續性正壓呼吸器（CPAP）面罩和下顎前突矯正器，往往會造成患者強烈的抵抗情緒。使用者經常反映，這些設備會直接導致身體不適、恐懼症和睡眠障礙，導致確診後不久便大量停止治療。這種對處方治療的不依從性直接影響了耗材和長期治療設備製造商的重要持續收入來源。

低治療依從率正顯著縮小潛在市場規模。根據美國國家睡眠基金會2025年的數據，約31%的睡眠呼吸中止症成年患者並未積極尋求治療。這項統計數據表明，大多數確診患者由於不適和缺乏持續治療的動力而退出市場。因此，儘管診斷率不斷上升，但該行業仍難以將患者的認知轉化為產品的持續使用，阻礙了潛在的收入成長，並限制了止鼾技術的整體市場滲透率。

市場趨勢

日間神經肌肉刺激（CMS）的出現標誌著治療方式從傳統的夜間干預轉向清醒狀態下的主動肌肉強化。與必須在睡眠期間使用的持續性正壓呼吸器（CPAP）設備和口腔矯正器不同，這些創新療法利用神經肌肉電刺激在患者清醒時增強上呼吸道肌肉的耐力。這種方法直接針對氣道阻塞的根本原因，無需夜間佩戴設備，從而顯著提高患者的治療依從性。例如，2025年2月，Signifier Medical Technologies公佈了其日間治療方法eXciteOSA的臨床數據，顯示其依從率超過80%，表明該產品有望解決與標準睡眠呼吸中止症治療相關的長期存在的治療依從性問題。

同時，採用3D列印技術客製化下顎矯正器的日益普及，正透過先進的精密工程和更佳的生物相容性，革新口內矯正器治療。製造商正利用醫用級3D列印技術生產高度個人化的矯正器，與傳統的熱成型矯正器相比，這些矯正器具有更優異的結構強度和更高的舒適度。這些先進的矯正器經過專門設計，可減少口腔內的體積，從而最大限度地減少下顎不適，並促進更自然的舌位。為了展現這項技術進步，ProSomnus Sleep Technologies公司宣布將於2025年6月推出EVO Guided矯正器。這款生物工程解決方案提供的舌部空間比傳統矯正器多出14倍，從而改善氣道通暢性，並融合了多項關鍵功能，確保患者即使在長時間佩戴的情況下也能保持舒適。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球止鼾設備與止鼾手術市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（口內矯正器/口含器、鼻腔矯正器、體位控制設備、顎帶、舌頭固定裝置、EPAP治療裝置）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美止鼾器與止鼾手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲止鼾器與止鼾手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區止鼾器和止鼾手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲地區止鼾設備和止鼾手術的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲止鼾設備與止鼾手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球止鼾設備與止鼾手術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Apnea Sciences Corp.
  • SomnoMed Ltd.
  • Airway Management, Inc.
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips NV
  • Sleep Well Enjoy Life, Ltd.
  • Tomed Dr. Toussaint GmbH
  • MEDiTAS Ltd.
  • Sleeping Well, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21638

The global market for anti-snoring devices and snoring surgery is projected to expand significantly, from USD 1.72 Billion in 2025 to USD 2.69 Billion by 2031, demonstrating a compound annual growth rate of 7.74%. This sector encompasses a range of solutions including non-invasive devices such as oral appliances, nasal dilators, and continuous positive airway pressure (CPAP) machines designed to ensure open airways, as well as surgical procedures aimed at correcting structural obstructions causing snoring. The primary drivers behind this expansion are the increasing worldwide prevalence of obesity and the growing elderly population, both demographics being highly prone to sleep-disordered breathing.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.72 Billion
Market Size 2031USD 2.69 Billion
CAGR 2026-20317.74%
Fastest Growing SegmentChin Straps
Largest MarketNorth America

For instance, the National Council on Aging reported that by 2025, approximately 56% of adults aged 65 and above face a high risk of developing obstructive sleep apnea, underscoring the strong link between age and sleep disorders and the resulting consistent demand for effective therapeutic options, both surgical and non-surgical. However, a key impediment to market growth is the challenge of patient adherence and comfort with these devices. A notable number of users experience discomfort or claustrophobia from CPAP masks or mandibular advancement devices, leading to high rates of therapy abandonment. This resistance to long-term treatment protocols restricts potential revenue for manufacturers and poses a significant hurdle to the widespread adoption of anti-snoring technologies globally.

Market Driver

The primary catalyst for market expansion is the escalating global incidence of Obstructive Sleep Apnea (OSA), largely driven by rising obesity rates and an aging worldwide population. As lifestyle-related respiratory ailments become more common, the number of individuals needing clinical intervention significantly increases, thereby boosting demand for advanced diagnostic tools and therapeutic options. This growing health burden is exemplified by projections, such as ResMed's August 2025 press release stating that OSA is expected to impact approximately 77 million U.S. adults by 2050. This surge in OSA prevalence directly translates into increased commercial activity and financial growth for leading companies in the industry.

Reflecting this economic impact, ResMed reported a quarterly revenue of $1.3 billion in 2025, fueled by consistent demand for sleep health devices and masks. Concurrently, a substantial increase in demand for minimally invasive surgical interventions is reshaping treatment approaches, especially for patients who struggle with adherence to conventional non-invasive therapies. Surgical alternatives like hypoglossal nerve stimulation are gaining popularity, providing lasting solutions for anatomical obstructions without the discomfort often associated with continuous positive airway pressure (CPAP) machines. Technological advancements further expedite the adoption of these procedures by enhancing patient outcomes and simplifying surgical complexity. For example, Inspire Medical Systems reported in November 2025 that over 75% of clinical centers were prepared to adopt their new Inspire V system, indicating a significant move towards advanced, minimally invasive treatments as a preferred method for managing severe sleep disorders.

Market Challenge

Patient adherence presents a significant obstacle to revenue generation in the anti-snoring and sleep surgery market. Although the widespread occurrence of sleep disorders suggests a broad adoption of treatment devices, the invasive nature of conventional therapies, particularly continuous positive airway pressure (CPAP) masks and mandibular advancement devices, often creates considerable resistance. Users frequently report physical discomfort, claustrophobia, and sleep disturbances directly attributable to the equipment, resulting in high rates of therapy discontinuation soon after diagnosis. This non-compliance with prescribed treatment directly impacts the recurring revenue streams crucial for manufacturers of consumable parts and long-term therapeutic hardware.

The extensive scale of this non-adherence substantially shrinks the achievable total addressable market. Data from the National Sleep Foundation in 2025 revealed that nearly 31% of adults diagnosed with sleep apnea were not actively undergoing treatment. This statistic highlights that a large portion of the diagnosed patient population effectively withdraws from the market due to discomfort or an unwillingness to continue therapy. Consequently, despite increasing diagnosis rates, the industry faces difficulty in converting patient awareness into consistent product usage, thereby impeding potential financial growth and restricting the overall market penetration of anti-snoring technologies.

Market Trends

A significant shift is occurring with the emergence of daytime neuromuscular stimulation therapies, moving away from conventional nighttime interventions towards active muscle strengthening during waking hours. Unlike continuous positive airway pressure (CPAP) machines or oral appliances that require use during sleep, these innovative therapies employ neuromuscular electrical stimulation to enhance the endurance of upper airway muscles while the patient is awake. This method directly tackles the underlying cause of airway collapse without the physical burden of nocturnal devices, thus substantially improving patient adherence. Signifier Medical Technologies, for instance, reported in February 2025 that clinical data for their eXciteOSA daytime therapy shows adherence rates exceeding 80%, confirming its potential to resolve the persistent non-compliance issues associated with standard sleep apnea treatments.

Concurrently, the increasing adoption of 3D-printed custom mandibular devices is transforming oral appliance therapy through advanced precision engineering and improved biocompatibility. Manufacturers are now utilizing medical-grade 3D printing to produce highly personalized splints that offer superior structural integrity and greater comfort compared to older thermoformed devices. These advanced appliances are specifically designed to reduce intraoral bulk, thereby minimizing the chance of jaw discomfort and promoting more natural tongue placement. Highlighting this technological advancement, ProSomnus Sleep Technologies announced in June 2025 the launch of their EVO Guided device, a bioengineered solution that provides up to 14 times more tongue space than previous devices, a crucial feature for improving airway patency and ensuring patient comfort during extended use.

Key Market Players

  • Apnea Sciences Corp.
  • SomnoMed Ltd.
  • Airway Management, Inc.
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips NV
  • Sleep Well Enjoy Life, Ltd.
  • Tomed Dr. Toussaint GmbH
  • MEDiTAS Ltd.
  • Sleeping Well, LLC

Report Scope

In this report, the Global Anti-snoring Devices and Snoring Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-snoring Devices and Snoring Surgery Market, By Type

  • Oral Appliances/Mouthpieces
  • Nasal Devices
  • Position Control Devices
  • Chin Straps
  • Tongue Stabilizing Devices
  • EPAP Therapy Devices

Anti-snoring Devices and Snoring Surgery Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-snoring Devices and Snoring Surgery Market.

Available Customizations:

Global Anti-snoring Devices and Snoring Surgery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-snoring Devices and Snoring Surgery Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps, Tongue Stabilizing Devices, EPAP Therapy Devices)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Anti-snoring Devices and Snoring Surgery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Anti-snoring Devices and Snoring Surgery Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Canada Anti-snoring Devices and Snoring Surgery Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Mexico Anti-snoring Devices and Snoring Surgery Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type

7. Europe Anti-snoring Devices and Snoring Surgery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Anti-snoring Devices and Snoring Surgery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. France Anti-snoring Devices and Snoring Surgery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Anti-snoring Devices and Snoring Surgery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Anti-snoring Devices and Snoring Surgery Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Anti-snoring Devices and Snoring Surgery Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Anti-snoring Devices and Snoring Surgery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Anti-snoring Devices and Snoring Surgery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Anti-snoring Devices and Snoring Surgery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. Japan Anti-snoring Devices and Snoring Surgery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. South Korea Anti-snoring Devices and Snoring Surgery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Anti-snoring Devices and Snoring Surgery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. Middle East & Africa Anti-snoring Devices and Snoring Surgery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Anti-snoring Devices and Snoring Surgery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. UAE Anti-snoring Devices and Snoring Surgery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. South Africa Anti-snoring Devices and Snoring Surgery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. South America Anti-snoring Devices and Snoring Surgery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Anti-snoring Devices and Snoring Surgery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Colombia Anti-snoring Devices and Snoring Surgery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. Argentina Anti-snoring Devices and Snoring Surgery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Anti-snoring Devices and Snoring Surgery Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Apnea Sciences Corp.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. SomnoMed Ltd.
  • 15.3. Airway Management, Inc.
  • 15.4. ResMed Inc.
  • 15.5. Fisher & Paykel Healthcare Corp. Ltd.
  • 15.6. Koninklijke Philips NV
  • 15.7. Sleep Well Enjoy Life, Ltd.
  • 15.8. Tomed Dr. Toussaint GmbH
  • 15.9. MEDiTAS Ltd.
  • 15.10. Sleeping Well, LLC

16. Strategic Recommendations

17. About Us & Disclaimer